Beyond Bites
CINCINNATI, OH – After an iconic history, the last Boeing 747-8 Freighter has rolled out of the Boeing plant in Everett, Washington. This marks the end of an era for the aviation giant, as the Boeing 747 played an integral part in the development of commercial aviation since its introduction in 1969. The iconic humpback design…
Latest
Are We There Yet?
How One MRO Company is Creatively Overcoming the Industry’s Talent Shortage
Fresh off the conclusion of the MRO Americas 2022 Aviation week, host Grant Harrell of the podcast “Are We There Yet?” sat down with Cam Murphy, the president of FEAM Aero — an aircraft maintenance company. The pair discussed the aviation industry, and how the global pandemic greatly affected various aspects of the field. But…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
